Vaginal Baclofen Suppositories in Chronic Pelvic Pain
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if baclofen vaginal suppositories improve symptoms
of Chronic Pelvic Pain (CPP).
Participants in this study will take four short questionnaires prior to being randomized.
Randomization is like flipping a coin; participants have an equal likelihood of being
randomized to the treatment group (vaginal baclofen suppositories) or placebo group (vaginal
suppository without baclofen ingredient). Participants will take their assigned treatment
nightly for 8 weeks. Follow up visits will be at the 4 and 8 week time frames, when
questionnaires will again be completed. Participants may receive additional treatments for
CPP during the course of the study. After 8 weeks Participants will be offered a prescription
for baclofen suppositories and the study drug will be stopped. Follow up on patient symptoms
with questionnaires will again occur at 12 weeks.